🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
Neuroendocrine tumors are rare but recent data showed a relevant increase i...
Status
Unknown
Location
Instituto do Cancer do Estado de São Paulo
Start Date
2014-03
Trial ID
NCT02279758
Treatments Being Tested
The purpose of this Phase 2a study is to evaluate the efficacy, safety and ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-07
Trial ID
NCT00473525
Treatments Being Tested
The purpose of this study is to determine the effects of LX4211 and metform...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2011-02
Trial ID
NCT01292993
Treatments Being Tested
The polycystic ovary syndrome is the most common endocrinopathy in reproduc...
Status
Unknown
Location
Federal University of Sao Paulo
Start Date
2011-07
Trial ID
NCT00988078
This research will help us to learn if the medicine called metformin reduce...
Status
Recruiting
Location
Phoenix VA Health Care System, Phoenix, AZ
Start Date
2023-04-03
Trial ID
NCT02915198
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness and safety of a ...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00231647
Treatments Being Tested
DiObex Inc. is developing an experimental drug (DIO-902) that is made up of...
Status
Terminated
Location
Dr. Terence Hart
Start Date
2008-01
Trial ID
NCT00622089
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
The primary objective of the study is to demonstrate superiority of rimonab...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00754689
Treatments Being Tested